Schrödinger Sees Unusually High Options Volume (NASDAQ:SDGR)

Schrödinger, Inc. (NASDAQ:SDGRGet Free Report) was the target of some unusual options trading on Friday. Stock investors purchased 11,950 call options on the company. This represents an increase of 1,122% compared to the average volume of 978 call options.

Schrödinger Price Performance

SDGR opened at $24.49 on Friday. The firm has a market capitalization of $1.79 billion, a PE ratio of -10.47 and a beta of 1.77. The business’s 50-day moving average is $21.98 and its two-hundred day moving average is $20.74. Schrödinger has a 1 year low of $16.60 and a 1 year high of $28.47.

Schrödinger (NASDAQ:SDGRGet Free Report) last posted its quarterly earnings data on Wednesday, February 26th. The company reported ($0.55) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.20). Schrödinger had a negative return on equity of 35.77% and a negative net margin of 91.84%. The business had revenue of $88.32 million during the quarter, compared to analyst estimates of $83.20 million. As a group, sell-side analysts expect that Schrödinger will post -2.37 EPS for the current year.

Wall Street Analyst Weigh In

A number of research firms have weighed in on SDGR. KeyCorp boosted their price objective on shares of Schrödinger from $25.00 to $27.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Piper Sandler cut their price target on shares of Schrödinger from $50.00 to $45.00 and set an “overweight” rating on the stock in a report on Thursday, February 27th. One equities research analyst has rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company has an average rating of “Buy” and a consensus target price of $32.29.

Check Out Our Latest Report on Schrödinger

Insider Buying and Selling at Schrödinger

In other news, CFO Geoffrey Craig Porges sold 5,491 shares of the business’s stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $21.76, for a total transaction of $119,484.16. Following the transaction, the chief financial officer now owns 27,544 shares of the company’s stock, valued at approximately $599,357.44. The trade was a 16.62 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 8.60% of the company’s stock.

Institutional Trading of Schrödinger

Several large investors have recently bought and sold shares of SDGR. Avanza Fonder AB acquired a new stake in shares of Schrödinger during the fourth quarter worth $577,000. Barclays PLC lifted its position in Schrödinger by 421.6% during the 3rd quarter. Barclays PLC now owns 107,554 shares of the company’s stock worth $1,995,000 after acquiring an additional 86,933 shares during the period. Raymond James Financial Inc. purchased a new stake in Schrödinger during the 4th quarter valued at about $325,000. State Street Corp increased its holdings in shares of Schrödinger by 1.8% in the third quarter. State Street Corp now owns 2,155,620 shares of the company’s stock valued at $39,987,000 after purchasing an additional 38,972 shares during the period. Finally, Sumitomo Mitsui Trust Group Inc. raised its stake in shares of Schrödinger by 60.2% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,510,518 shares of the company’s stock worth $67,718,000 after purchasing an additional 1,319,464 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Schrödinger Company Profile

(Get Free Report)

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.

Further Reading

Receive News & Ratings for Schrödinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrödinger and related companies with MarketBeat.com's FREE daily email newsletter.